Diffuse large B cell lymphoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Mahshid |
||
Line 17: | Line 17: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] |
Revision as of 22:12, 26 November 2017
Diffuse large B cell lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Diffuse large B cell lymphoma risk factors On the Web |
American Roentgen Ray Society Images of Diffuse large B cell lymphoma risk factors |
Directions to Hospitals Treating Diffuse large B cell lymphoma |
Risk calculators and risk factors for Diffuse large B cell lymphoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
The most potent risk factor in the development of diffuse large B cell lymphoma is immunodeficiency.
Risk factors
- An underlying immunodeficiency is a significant risk factor.